Orbillion Bio, a California-based cell-cultured meat developer, partnered with Solar Biotech—a leader in bioprocessing technology—to develop and scale up the production of cultivated wagyu beef.

This partnership will leverage Orbillion’s proprietary cell culture platform along with bioprocessing capabilities and infrastructure, AI-driven bioprocess controlling software, biosensing technologies, and vertically integrated engineering of Solar Biotech.

Together, the companies aim to scale production to over 4 million lbs of beef annually. Orbillion Bio believes this will further aid the company in achieving its goal of price parity by allowing it to keep production costs low.

Analyst QuickTake: While the US is taking massive strides towards approving the sale of cell-cultured meat, a key barrier that stands in the way of consumer adoption is the high price associated with cultivated meat, which stems from higher production costs. Orbillion Bio developed its own serum-free media which allowed the company to reduce its media cost down to USD 2 per liter. With this partnership helping to keep costs further down, Orbillion would be in a position to achieve its targets of price parity by 2026 and commodity pricing for its beef by 2030.